Huang Xiang, Li Xiao-Lan, Zhou Heng, Li Xiao-Mei
Department of Cardiology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang 441000, Hubei, China.
Cardiovasc Ther. 2024 Jan 9;2024:4618868. doi: 10.1155/2024/4618868. eCollection 2024.
Quantitative flow ratio (QFR) is an angiography-based fractional flow reserve measurement without pressure wire or induction of hyperemia. A recent innovation that uses combined geometrical data and hemodynamic boundary conditions to measure QFR from a single angiographic view has shown the potential to measure QFR of the renal artery-renal QFR (rQFR).
The aim of this pilot study was to assess the feasibility of rQFR measurement and the contribution of rQFR in selecting patients with atherosclerotic renal artery stenosis (ARAS) undergoing revascularization.
This retrospective trial enrolled patients who had ARAS (50-90%) and hypertension. The enrolled patients were treated by optimal antihypertensive medication or revascularization, respectively, and the therapeutic strategies were based on rFFR measurement and/or clinical feature.
A total of 55 patients underwent rQFR measurement. Among the enrolled patients, 18 underwent optimal antihypertensive medication and 37 underwent revascularization, 19 patients in whom rQFR and rFFR were both assessed. During the 180-day follow-up, 25 patients saw an improvement in their blood pressure among the 37 patients that underwent revascularization. ROC analysis revealed that rQFR had a high diagnostic accuracy for predicting blood pressure improvement (AUC = 0.932, 95% CI 0.798-0.998). The ideal cut-off value of rQFR for predicting blood pressure improvement after revascularization is ≤0.72 (sensitivity: 72.00%, specificity: 100%). The paired test and Bland-Altman analyses demonstrated good agreement between rQFR and rFFR ( = 1.887, 95% CI -0.021 to 0.001, 95% limits of agreement: -0.035 to 0.055, = 0.075). The Spearman correlation test reveals that there was a significant positive correlation between rQFR and rFFR ( = 0.952, 95% CI 0.874 to 0.982, < 0.001).
The rQFR has the potential to enhance the ability of angiography to detect functionally significant renal artery stenosis during angiography and to produce results that are comparable to invasive hemodynamic assessment.
定量血流比(QFR)是一种基于血管造影的血流储备分数测量方法,无需使用压力导丝或诱发充血。最近的一项创新技术利用几何数据和血流动力学边界条件的组合,从单一血管造影视图测量QFR,显示出测量肾动脉QFR(rQFR)的潜力。
本初步研究的目的是评估rQFR测量的可行性以及rQFR在选择接受血运重建的动脉粥样硬化性肾动脉狭窄(ARAS)患者中的作用。
这项回顾性试验纳入了患有ARAS(50%-90%)和高血压的患者。纳入的患者分别接受了最佳抗高血压药物治疗或血运重建,治疗策略基于rFFR测量和/或临床特征。
共有55例患者接受了rQFR测量。在纳入的患者中,18例接受了最佳抗高血压药物治疗,37例接受了血运重建,其中19例患者同时评估了rQFR和rFFR。在为期180天的随访中,37例接受血运重建的患者中有25例血压有所改善。ROC分析显示,rQFR在预测血压改善方面具有较高的诊断准确性(AUC = 0.932,95%CI 0.798-0.998)。预测血运重建后血压改善的rQFR理想截断值为≤0.72(敏感性:72.00%,特异性:100%)。配对t检验和Bland-Altman分析表明rQFR与rFFR之间具有良好的一致性(t = 1.887,95%CI -0.021至0.001,95%一致性界限:-0.035至0.055,P = 0.075)。Spearman相关性检验显示rQFR与rFFR之间存在显著正相关(r = 0.952,95%CI 0.874至0.982,P < 0.001)。
rQFR有可能增强血管造影在血管造影过程中检测功能性显著肾动脉狭窄的能力,并产生与侵入性血流动力学评估相当的结果。